Stay updated on Pembrolizumab in NSCLC with PS 2 Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in NSCLC with PS 2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in NSCLC with PS 2 Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Summary: The page now displays a funding-status notice and announces a major version upgrade to v3.2.0, replacing the previous v3.1.0.
    Difference
    3%
    Check dated 2025-10-05T17:25:44.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T10:15:04.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.
    Difference
    0.2%
    Check dated 2025-09-14T00:21:13.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, and a 'Back to Top' feature has been added.
    Difference
    0.2%
    Check dated 2025-09-06T21:06:13.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, while key content related to pembrolizumab and various medical topics has been removed.
    Difference
    1%
    Check dated 2025-08-30T15:28:01.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T11:52:39.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in NSCLC with PS 2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in NSCLC with PS 2 Clinical Trial page.